Annual Operating Profit
-$93.65 M
+$37.72 M+28.71%
31 December 2023
Summary:
Protagonist Therapeutics annual operaing income is currently -$93.65 million, with the most recent change of +$37.72 million (+28.71%) on 31 December 2023. During the last 3 years, it has risen by +$32.19 million (+25.58%). PTGX annual operating profit is now -904.96% below its all-time high of -$9.32 million, reached on 31 December 2014.PTGX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$41.45 M
-$2.66 M-6.86%
30 September 2024
Summary:
Protagonist Therapeutics quarterly operating income is currently -$41.45 million, with the most recent change of -$2.66 million (-6.86%) on 30 September 2024. Over the past year, it has dropped by -$64.50 million (-279.85%). PTGX quarterly operating profit is now -120.09% below its all-time high of $206.31 million, reached on 31 March 2024.PTGX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
$149.11 M
-$3.13 M-2.05%
30 September 2024
Summary:
Protagonist Therapeutics TTM operating income is currently $149.11 million, with the most recent change of -$3.13 million (-2.05%) on 30 September 2024. Over the past year, it has increased by +$242.76 million (+259.22%). PTGX TTM operating profit is now -2.05% below its all-time high of $152.24 million, reached on 30 June 2024.PTGX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTGX Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -279.9% | +259.2% |
| 3 y3 years | +25.6% | -12.0% | +218.5% |
| 5 y5 years | -16.3% | -139.6% | +285.2% |
PTGX Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +28.7% | -120.1% | +2.1% | -2.0% | +197.3% |
| 5 y | 5 years | -45.2% | +28.7% | -120.1% | +2.1% | -2.0% | +197.3% |
| alltime | all time | -905.0% | +28.7% | -120.1% | +2.1% | -2.0% | +197.3% |
Protagonist Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$41.45 M(+6.9%) | $149.11 M(-2.1%) |
| June 2024 | - | -$38.79 M(-118.8%) | $152.24 M(+2.4%) |
| Mar 2024 | - | $206.31 M(+795.1%) | $148.68 M(-258.8%) |
| Dec 2023 | -$93.65 M(-28.7%) | $23.05 M(-160.1%) | -$93.65 M(-38.9%) |
| Sept 2023 | - | -$38.33 M(-9.5%) | -$153.22 M(+4.1%) |
| June 2023 | - | -$42.35 M(+17.6%) | -$147.19 M(+0.6%) |
| Mar 2023 | - | -$36.02 M(-1.4%) | -$146.28 M(+11.3%) |
| Dec 2022 | -$131.37 M(+4.4%) | -$36.52 M(+13.0%) | -$131.37 M(-0.4%) |
| Sept 2022 | - | -$32.30 M(-22.1%) | -$131.87 M(-1.2%) |
| June 2022 | - | -$41.44 M(+96.3%) | -$133.50 M(+8.6%) |
| Mar 2022 | - | -$21.11 M(-43.0%) | -$122.94 M(-2.3%) |
| Dec 2021 | -$125.84 M(+95.1%) | -$37.02 M(+9.1%) | -$125.84 M(+16.9%) |
| Sept 2021 | - | -$33.93 M(+9.9%) | -$107.66 M(+32.1%) |
| June 2021 | - | -$30.88 M(+28.6%) | -$81.50 M(+18.4%) |
| Mar 2021 | - | -$24.02 M(+27.6%) | -$68.84 M(+6.7%) |
| Dec 2020 | -$64.52 M(-19.9%) | -$18.83 M(+142.3%) | -$64.52 M(+2.4%) |
| Sept 2020 | - | -$7.77 M(-57.3%) | -$62.98 M(-13.0%) |
| June 2020 | - | -$18.22 M(-7.5%) | -$72.38 M(-15.4%) |
| Mar 2020 | - | -$19.70 M(+13.9%) | -$85.57 M(+6.3%) |
| Dec 2019 | -$80.52 M | -$17.30 M(+0.8%) | -$80.52 M(+2.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | -$17.17 M(-45.3%) | -$78.63 M(+11.0%) |
| June 2019 | - | -$31.41 M(+114.4%) | -$70.86 M(+45.5%) |
| Mar 2019 | - | -$14.65 M(-5.0%) | -$48.69 M(+15.2%) |
| Dec 2018 | -$42.27 M(+11.5%) | -$15.41 M(+64.1%) | -$42.27 M(+39.2%) |
| Sept 2018 | - | -$9.39 M(+1.6%) | -$30.37 M(+17.0%) |
| June 2018 | - | -$9.24 M(+12.3%) | -$25.96 M(-18.5%) |
| Mar 2018 | - | -$8.23 M(+134.2%) | -$31.85 M(-15.9%) |
| Dec 2017 | -$37.90 M(+16.0%) | -$3.51 M(-29.5%) | -$37.90 M(-17.2%) |
| Sept 2017 | - | -$4.98 M(-67.1%) | -$45.78 M(-4.5%) |
| June 2017 | - | -$15.13 M(+6.0%) | -$47.94 M(+20.2%) |
| Mar 2017 | - | -$14.27 M(+25.2%) | -$39.90 M(+22.1%) |
| Dec 2016 | -$32.67 M(+120.8%) | -$11.40 M(+59.7%) | -$32.67 M(+24.3%) |
| Sept 2016 | - | -$7.14 M(+0.7%) | -$26.27 M(+13.5%) |
| June 2016 | - | -$7.09 M(+0.7%) | -$23.15 M(+20.9%) |
| Mar 2016 | - | -$7.04 M(+40.8%) | -$19.14 M(+29.4%) |
| Dec 2015 | -$14.79 M(+58.8%) | -$5.00 M(+24.4%) | -$14.79 M(+51.1%) |
| Sept 2015 | - | -$4.02 M(+30.4%) | -$9.79 M(+69.7%) |
| June 2015 | - | -$3.08 M(+14.7%) | -$5.77 M(+114.7%) |
| Mar 2015 | - | -$2.69 M | -$2.69 M |
| Dec 2014 | -$9.32 M | - | - |
FAQ
- What is Protagonist Therapeutics annual operaing income?
- What is the all time high annual operating profit for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly operating profit year-on-year change?
- What is Protagonist Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Protagonist Therapeutics?
- What is Protagonist Therapeutics TTM operating profit year-on-year change?
What is Protagonist Therapeutics annual operaing income?
The current annual operating profit of PTGX is -$93.65 M
What is the all time high annual operating profit for Protagonist Therapeutics?
Protagonist Therapeutics all-time high annual operaing income is -$9.32 M
What is Protagonist Therapeutics quarterly operating income?
The current quarterly operating profit of PTGX is -$41.45 M
What is the all time high quarterly operating profit for Protagonist Therapeutics?
Protagonist Therapeutics all-time high quarterly operating income is $206.31 M
What is Protagonist Therapeutics quarterly operating profit year-on-year change?
Over the past year, PTGX quarterly operating income has changed by -$64.50 M (-279.85%)
What is Protagonist Therapeutics TTM operating income?
The current TTM operating profit of PTGX is $149.11 M
What is the all time high TTM operating profit for Protagonist Therapeutics?
Protagonist Therapeutics all-time high TTM operating income is $152.24 M
What is Protagonist Therapeutics TTM operating profit year-on-year change?
Over the past year, PTGX TTM operating income has changed by +$242.76 M (+259.22%)